Investments abroad · Corporate investor · Switzerland

Novartis Venture Fund's investments in the United States

Novartis Venture Fund, based in Switzerland, has backed 27 startups in the United States in rounds we track, $2.2B between them, grouped by their main sector.

27startups backed
3sectors
$2.2Braised between them
Biotechbiggest sector

Novartis Venture Fund's profile

Biotech

22

Pharma

3

Healthtech

2

Segment by segment

Biotech

22 startups · $2.0B raised

  1. Aeglea BioTherapeuticsAeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.United States$266M
  2. Galera TherapeuticsGalera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.United States$219M
  3. CTCapstan TherapeuticsCapstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.United States$175M
  4. CelladonCelladon is a biotechnology company developing molecular therapies for the treatment of heart failure.United States$172M
  5. FORMA TherapeuticsFORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.United States$143M
  6. Sidewinder TherapeuticsSidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.United States$137M
  7. FORE BiotherapeuticsFore Biotherapeutics is a clinical-stage precision oncology company based in Philadelphia, PA.United States$108M
  8. EpiBiologicsEpiBiologics is a biotechnology company based in San Mateo, California, founded in 2022.United States$107M

Pharma

3 startups · $217M raised

  1. Protego BiopharmaProtego Biopharma is a California-based biotechnology company that researches and develops small-molecule therapeutics for the treUnited States$130M
  2. Thesan PharmaceuticalsThesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.United States$65M
  3. AFAblation FrontiersA develops and markets cardiac ablation devices for the treatment of individuals suffering from atrial fibrillation.United States$22M

Healthtech

2 startups · $38M raised

  1. Advanced Animal DiagnosticsAdvanced Animal Diagnostics (AAD) is a biotechnology company based in Morrisville, North Carolina, established in 2001.United States$20M
  2. ATAscent TherapeuticsAscent Therapeutics offers Pepducins targeting GPCRs on the cell membrane, expanding the GPCR frontier.United States$19M

How this map is made. Every startup here has raised money in a round we track that names Novartis Venture Fund as an investor and is based in United States. Each sits under its main sector, read from its rounds, and each shows its best-funded first. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Novartis Venture Fund52 co-investorsSector portfolioNovartis Venture Fund's Biotech portfolio39 startups · $3.3BInvestments abroadM Ventures' investments in the United States54 startups · $1.7BInvestments abroadIndex Ventures' investments in the United States217 startups · $50BInvestments abroadBossa Invest's investments in the United States161 startups · $6.5BInvestments abroadVillage Global's investments in the United States127 startups · $6.5B

Raising from investors like Novartis Venture Fund?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps